InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,190.81
(
0.19%
)
US TECH 100
17,612.40
(
0.01%
)
Dow Jones
38,970.30
(
0.30%
)
Brent Oil
82.61
(
-1.04%
)
Bitcoin
63,382.56
(
0.34%
)
Post# of 9401
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

KILLAZILLA

Send PM Follow Ignore
Followers 42
Posts 9193
Boards Moderated 0
Alias Born 05/28/2020

KILLAZILLA

Re: excboe post# 417

Wednesday, 07/29/2020 9:23:55 PM

Wednesday, July 29, 2020 9:23:55 PM

Post# of 9401
Pretty sure some of the drugs they're working on will be effective to treat most all substance related additions. Don't know if they have to prove each individual one or as a group?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MNMD News
More MNMD News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!